Drug-maker Mallinckrodt may renege on $1.7 billion opioid settlement

Mallinckrodt says it is considering its financial alternatives, including a second bankruptcy, and might not make a $200 million opioid payment next week.Whitney Curtis/AP The generic drug-maker Mallinckrodt says the company's board might not make a $200 million opioid settlement payment scheduled for later this week.

Read at www.npr.org